000 01426 a2200397 4500
005 20250513145306.0
264 0 _c19980917
008 199809s 0 0 eng d
022 _a0342-4642
024 7 _a10.1007/s001340050605
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKamper, E F
245 0 0 _aModulation of rat brain synaptosomal plasma membrane achieved by atracurium and its metabolite laudanosine.
_h[electronic resource]
260 _bIntensive care medicine
_cMay 1998
300 _a519-25 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a5'-Nucleotidase
_xdrug effects
650 0 4 _aAnimals
650 0 4 _aAtracurium
_xpharmacology
650 0 4 _aBrain
_xdrug effects
650 0 4 _aCa(2+) Mg(2+)-ATPase
_xdrug effects
650 0 4 _aCell Membrane
_xdrug effects
650 0 4 _aCentral Nervous System Agents
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aIsoquinolines
_xpharmacology
650 0 4 _aMale
650 0 4 _aNeuromuscular Depolarizing Agents
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSodium-Potassium-Exchanging ATPase
_xdrug effects
650 0 4 _aSynaptosomes
_xdrug effects
700 1 _aSiafaka, J
700 1 _aStavridis, J
773 0 _tIntensive care medicine
_gvol. 24
_gno. 5
_gp. 519-25
856 4 0 _uhttps://doi.org/10.1007/s001340050605
_zAvailable from publisher's website
999 _c9626312
_d9626312